{
    "@context": {
        "schema": "https://schema.org/",
        "dct": "http://purl.org/dc/terms/",
        "hg": "https://hormuz.group/data/ns#"
    },
    "id": "hg:company:pakhsh-alborz-company",
    "identifier": "hg:company:pakhsh-alborz-company",
    "dataset_type": "entity_dataset",
    "entity_type": "company",
    "data_version": "2.0",
    "generated_by": "Hormuz Data Layer 0.2.1",
    "generated_at": "2026-07-04T02:51:17+00:00",
    "name": "Pakhsh Alborz Company",
    "slug": "pakhsh-alborz-company",
    "status": "publish",
    "url": "https://hormuz.group/companies/pakhsh-alborz-company/",
    "json_url": "https://hormuz.group/wp-content/uploads/hormuz-data/cpt/company/pakhsh-alborz-company.json",
    "rest_url": "https://hormuz.group/wp-json/hormuz-data/v1/cpt/company/pakhsh-alborz-company",
    "summary": "",
    "machine_summary": "Pakhsh Alborz Company Pakhsh Alborz Company is a listed pharmaceutical and consumer-goods distribution company based in Tehran and affiliated with Alborz Investment Company. In the Hormuz Group company graph, it matters because medicine availability, pharmacy supply, controlled-drug logistics, cold-chain distribution, and healthcare resilience depend on large nationwide distributors. Its listed status makes it useful for monitoring the economics of Iran's distribution layer rather than only drug production. Pakhsh Alborz is relevant for investors assessing Iran's pharmaceutical distribution sector, cold-chain logistics, pharmacy coverage, medical-equipment distribution, consumer-health supply, FMCG distribution, and working-capital pressure in regulated healthcare markets. It can support analysis of medicine shortages, receivables from pharmacies and institutions, distributor margins, supplier concentration, inventory risk, and the financial impact of inflation and delayed payments. Due diligence should review updated Codal disclosures, IFB trading status, warehouse and branch network, supplier mix, controlled-drug handling, cold-chain quality, customer concentration, receivables aging, financing costs, regulatory compliance, and exposure to currency or import restrictions. Pakhsh Alborz Company distributes pharmaceuticals, medical equipment, consumer health products, food products, detergents, hygienic goods, narcotic and controlled medicines, cold-chain items, and related healthcare and FMCG products. Its activity includes nationwide warehousing, branch operations, pharmacy and healthcare-center supply, consumer-goods distribution, GSP and GDP-compliant logistics, cold-chain handling, order fulfillment, and supplier-to-retail distribution services. province: Tehran industry: Healthcare & Pharma, Logistics & Transport, Pharmaceuticals market: Business Services, Consumer Demand, Healthcare, Supply Chains challenges: Compliance, Counterparty Risk, Logistics Gap, Supply Shortage company_type: Distributor, Service Provider city: Tehran",
    "published_at": "2026-06-28T20:36:00+00:00",
    "modified_at": "2026-06-28T20:36:00+00:00",
    "taxonomies": {
        "province": [
            {
                "id": 3,
                "name": "Tehran",
                "slug": "tehran",
                "url": "https://hormuz.group/provinces/tehran/"
            }
        ],
        "industry": [
            {
                "id": 21,
                "name": "Healthcare & Pharma",
                "slug": "healthcare-pharma",
                "url": "https://hormuz.group/industry/healthcare-pharma/"
            },
            {
                "id": 19,
                "name": "Logistics & Transport",
                "slug": "logistics-transport",
                "url": "https://hormuz.group/industry/logistics-transport/"
            },
            {
                "id": 121,
                "name": "Pharmaceuticals",
                "slug": "pharmaceuticals",
                "url": "https://hormuz.group/industry/healthcare-pharma/pharmaceuticals/"
            }
        ],
        "market": [
            {
                "id": 75,
                "name": "Business Services",
                "slug": "business-services",
                "url": "https://hormuz.group/market/enterprise-demand/business-services/"
            },
            {
                "id": 34,
                "name": "Consumer Demand",
                "slug": "consumer-demand",
                "url": "https://hormuz.group/market/consumer-demand/"
            },
            {
                "id": 69,
                "name": "Healthcare",
                "slug": "healthcare",
                "url": "https://hormuz.group/market/consumer-demand/healthcare/"
            },
            {
                "id": 76,
                "name": "Supply Chains",
                "slug": "supply-chains",
                "url": "https://hormuz.group/market/enterprise-demand/supply-chains/"
            }
        ],
        "challenges": [
            {
                "id": 164,
                "name": "Compliance",
                "slug": "compliance",
                "url": "https://hormuz.group/challenges/regulatory-barriers/compliance/"
            },
            {
                "id": 184,
                "name": "Counterparty Risk",
                "slug": "counterparty-risk",
                "url": "https://hormuz.group/challenges/operational-risks/counterparty-risk/"
            },
            {
                "id": 170,
                "name": "Logistics Gap",
                "slug": "logistics-gap",
                "url": "https://hormuz.group/challenges/infrastructure-gaps/logistics-gap/"
            },
            {
                "id": 177,
                "name": "Supply Shortage",
                "slug": "supply-shortage",
                "url": "https://hormuz.group/challenges/market-gaps/supply-shortage/"
            }
        ],
        "company_type": [
            {
                "id": 302,
                "name": "Distributor",
                "slug": "distributor",
                "url": "https://hormuz.group/company-type/distributor/"
            },
            {
                "id": 303,
                "name": "Service Provider",
                "slug": "service-provider",
                "url": "https://hormuz.group/company-type/service-provider/"
            }
        ],
        "city": [
            {
                "id": 384,
                "name": "Tehran",
                "slug": "tehran",
                "url": "https://hormuz.group/cities/tehran/"
            }
        ]
    },
    "taxonomy_labels": {
        "province": "Tehran",
        "industry": "Healthcare & Pharma, Logistics & Transport, Pharmaceuticals",
        "market": "Business Services, Consumer Demand, Healthcare, Supply Chains",
        "challenges": "Compliance, Counterparty Risk, Logistics Gap, Supply Shortage",
        "company_type": "Distributor, Service Provider",
        "city": "Tehran"
    },
    "fields_summary": {
        "legal_name": "Pakhsh Alborz Company Public Joint Stock Company",
        "website": "https://alborzdc.com",
        "city": "Tehran, Tehran Province, Iran",
        "ticker_symbol": "پخش",
        "listing_status": "listed_ifb",
        "products_services": "Pakhsh Alborz Company distributes pharmaceuticals, medical equipment, consumer health products, food products, detergents, hygienic goods, narcotic and controlled medicines, cold-chain items, and related healthcare and FMCG products. Its activity includes nationwide warehousing, branch operations, pharmacy and healthcare-center supply, consumer-goods distribution, GSP and GDP-compliant logistics, cold-chain handling, order fulfillment, and supplier-to-retail distribution services.",
        "export_relevance": "low",
        "short_profile": "Pakhsh Alborz Company is a listed pharmaceutical and consumer-goods distribution company based in Tehran and affiliated with Alborz Investment Company. In the Hormuz Group company graph, it matters because medicine availability, pharmacy supply, controlled-drug logistics, cold-chain distribution, and healthcare resilience depend on large nationwide distributors. Its listed status makes it useful for monitoring the economics of Iran's distribution layer rather than only drug production.",
        "investment_relevance": "Pakhsh Alborz is relevant for investors assessing Iran's pharmaceutical distribution sector, cold-chain logistics, pharmacy coverage, medical-equipment distribution, consumer-health supply, FMCG distribution, and working-capital pressure in regulated healthcare markets. It can support analysis of medicine shortages, receivables from pharmacies and institutions, distributor margins, supplier concentration, inventory risk, and the financial impact of inflation and delayed payments. Due diligence should review updated Codal disclosures, IFB trading status, warehouse and branch network, supplier mix, controlled-drug handling, cold-chain quality, customer concentration, receivables aging, financing costs, regulatory compliance, and exposure to currency or import restrictions."
    },
    "fields": {
        "rank_math_internal_links_processed": "1",
        "wp_statistics_words_count": "0",
        "legal_name": "Pakhsh Alborz Company Public Joint Stock Company",
        "city": "Tehran, Tehran Province, Iran",
        "ticker_symbol": "پخش",
        "export_relevance": "low",
        "verification_status": "basic",
        "data_confidence": "high",
        "listing_status": "listed_ifb",
        "last_updated": "29/06/2026",
        "website": "https://alborzdc.com",
        "products_services": "Pakhsh Alborz Company distributes pharmaceuticals, medical equipment, consumer health products, food products, detergents, hygienic goods, narcotic and controlled medicines, cold-chain items, and related healthcare and FMCG products. Its activity includes nationwide warehousing, branch operations, pharmacy and healthcare-center supply, consumer-goods distribution, GSP and GDP-compliant logistics, cold-chain handling, order fulfillment, and supplier-to-retail distribution services.",
        "short_profile": "Pakhsh Alborz Company is a listed pharmaceutical and consumer-goods distribution company based in Tehran and affiliated with Alborz Investment Company. In the Hormuz Group company graph, it matters because medicine availability, pharmacy supply, controlled-drug logistics, cold-chain distribution, and healthcare resilience depend on large nationwide distributors. Its listed status makes it useful for monitoring the economics of Iran's distribution layer rather than only drug production.",
        "investment_relevance": "Pakhsh Alborz is relevant for investors assessing Iran's pharmaceutical distribution sector, cold-chain logistics, pharmacy coverage, medical-equipment distribution, consumer-health supply, FMCG distribution, and working-capital pressure in regulated healthcare markets. It can support analysis of medicine shortages, receivables from pharmacies and institutions, distributor margins, supplier concentration, inventory risk, and the financial impact of inflation and delayed payments. Due diligence should review updated Codal disclosures, IFB trading status, warehouse and branch network, supplier mix, controlled-drug handling, cold-chain quality, customer concentration, receivables aging, financing costs, regulatory compliance, and exposure to currency or import restrictions.",
        "source_note": "Based on public company, official-company, pharmaceutical-distribution, consumer-goods distribution, cold-chain logistics, IFB/Codal disclosure, healthcare, and market-related information. Further verification is required before treating this profile as verified investment intelligence."
    },
    "field_profile": {
        "rank_math_internal_links_processed": {
            "type": "string",
            "present": true,
            "length": 1
        },
        "wp_statistics_words_count": {
            "type": "string",
            "present": true,
            "length": 1
        },
        "legal_name": {
            "type": "string",
            "present": true,
            "length": 48
        },
        "city": {
            "type": "string",
            "present": true,
            "length": 29
        },
        "ticker_symbol": {
            "type": "string",
            "present": true,
            "length": 6
        },
        "export_relevance": {
            "type": "string",
            "present": true,
            "length": 3
        },
        "verification_status": {
            "type": "string",
            "present": true,
            "length": 5
        },
        "data_confidence": {
            "type": "string",
            "present": true,
            "length": 4
        },
        "listing_status": {
            "type": "string",
            "present": true,
            "length": 10
        },
        "last_updated": {
            "type": "string",
            "present": true,
            "length": 10
        },
        "website": {
            "type": "string",
            "present": true,
            "length": 20
        },
        "products_services": {
            "type": "string",
            "present": true,
            "length": 485
        },
        "short_profile": {
            "type": "string",
            "present": true,
            "length": 490
        },
        "investment_relevance": {
            "type": "string",
            "present": true,
            "length": 781
        },
        "source_note": {
            "type": "string",
            "present": true,
            "length": 287
        }
    },
    "sources": [
        {
            "type": "note",
            "value": "Based on public company, official-company, pharmaceutical-distribution, consumer-goods distribution, cold-chain logistics, IFB/Codal disclosure, healthcare, and market-related information. Further verification is required before treating this profile as verified investment intelligence."
        }
    ],
    "quality": {
        "required_fields": [
            "legal_name",
            "website",
            "city",
            "listing_status",
            "products_services",
            "export_relevance",
            "verification_status",
            "data_confidence",
            "short_profile",
            "investment_relevance",
            "source_note",
            "last_updated"
        ],
        "missing_required_fields": [],
        "missing_required_count": 0,
        "verification_status": "basic",
        "data_confidence": "high",
        "last_updated": "29/06/2026",
        "stale_over_180_days": false,
        "quality_score": 100
    },
    "verification": {
        "verification_status": "basic",
        "data_confidence": "high",
        "last_updated": "29/06/2026"
    }
}